Caligan Partners LP 13D and 13G filings for Y-mAbs Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 2:34 pm Sale | 2025-09-30 | 13G | Y-MABS THERAPEUTICS INC YMAB | Caligan Partners LP | 0 0.000% | -2,342,609 (Position Closed) | Filing |
| 2025-05-14 08:41 am Purchase | 2025-03-31 | 13G | Y-MABS THERAPEUTICS INC YMAB | Caligan Partners LP | 2,342,609 5.200% | 2,342,609 (New Position) | Filing |